Opioid-induced itching: Morphine sulfate and hydromorphone hydrochloride

Journal of Pain and Symptom Management

Volumn 17, Issue 1, 1999, Pages 70-72

  Katcher, Jerald ^a   Walsh, Declan ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hydromorphone; Itch; Morphine; Opioid side effects; Parenteral opioids

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; HISTAMINE; HYDROMORPHONE; IMMUNOGLOBULIN A; MORPHINE SULFATE; OPIATE; OPIATE RECEPTOR;

ADULT; ARTICLE; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PAIN; PRURITUS;

ANALGESICS, OPIOID; HUMANS; HYDROMORPHONE; MALE; MIDDLE AGED; MORPHINE; PAIN, INTRACTABLE; PALLIATIVE CARE; PRURITUS;

EID: 0032894687     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00115-8     Document Type: Article

References (10)

1. Walsh T.D. Prevention of opioid side effects. J Pain Symptom Manage. 6:1990;362-367.
2. Chaplan S.et al. Morphine and hydromorphone epidural analgesia. Anesthesiology. 77:1992;1090-1094.
3. Beaver W.T. Management of cancer pain with parenteral medication. J Am Med Assoc. 244:1980;2653-2657.
4. Stoelting R.K. Pharmacology and physiology in anesthetic practice. 2:1991;Lippincott, Philadelphia.
5. Etches RC. Complications of acute pain management. In: Anesthesiology clinics of North America: current concepts in acute pain control. Philadelphia: Saunders, 1992;417-433.
6. Davies D. Skin disorders. Textbook of adverse drug reactions, 2nd ed. Oxford University Press, 1981;420-421.
7. Fraki J.E.et al. Comparison of the human skin chymotrypsin-like proteinase with cathespin g and its location within skin. Clin Res. 30:1982;584A.
8. Dunteman E., Karanikolas M., Filtos K.S. Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines. J Pain Symptom Manage. 12:1996;255-260.
9. Hermens J.M., Hanifin J.M., Hirshman C.A. Comparison of histamine release in human skin mast cells induced by morphine and fentanyl as supplements to nitrous oxide anesthesia. Anesthesiology. 62:1985;124-129.
10. Glare P., Walsh T.D. Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol. 973-978:1993.